- Home
- XFOR vs LUD Comparison
XFOR vs LUD Comparison
Compare XFOR & LUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- LUD
- Stock Information
- Founded
- XFOR 2014
- LUD 2004
- Country
- XFOR United States
- LUD Hong Kong
- Employees
- XFOR N/A
- LUD N/A
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- LUD
- Sector
- XFOR Health Care
- LUD
- Exchange
- XFOR Nasdaq
- LUD NYSE
- Market Cap
- XFOR 118.4M
- LUD 96.7M
- IPO Year
- XFOR N/A
- LUD 2025
- Fundamental
- Price
- XFOR $1.48
- LUD $4.35
- Analyst Decision
- XFOR Strong Buy
- LUD
- Analyst Count
- XFOR 3
- LUD 0
- Target Price
- XFOR $72.33
- LUD N/A
- AVG Volume (30 Days)
- XFOR 466.4K
- LUD 35.1K
- Earning Date
- XFOR 08-07-2025
- LUD 01-01-0001
- Dividend Yield
- XFOR N/A
- LUD N/A
- EPS Growth
- XFOR N/A
- LUD N/A
- EPS
- XFOR 2.16
- LUD N/A
- Revenue
- XFOR $31,364,000.00
- LUD $44,863,430.00
- Revenue This Year
- XFOR $1,106.53
- LUD N/A
- Revenue Next Year
- XFOR N/A
- LUD N/A
- P/E Ratio
- XFOR $0.66
- LUD N/A
- Revenue Growth
- XFOR N/A
- LUD N/A
- 52 Week Low
- XFOR $1.41
- LUD $3.40
- 52 Week High
- XFOR $26.96
- LUD $8.00
- Technical
- Relative Strength Index (RSI)
- XFOR 25.85
- LUD N/A
- Support Level
- XFOR $1.81
- LUD N/A
- Resistance Level
- XFOR $2.12
- LUD N/A
- Average True Range (ATR)
- XFOR 0.21
- LUD 0.00
- MACD
- XFOR -0.01
- LUD 0.00
- Stochastic Oscillator
- XFOR 1.88
- LUD 0.00
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About LUD LUDA TECHNOLOGY GROUP LIMITED
Luda Technology Group Ltd is a company that is principally engaged in the manufacture and sale of stainless steel and carbon steel flanges and fittings products and trading of steel pipes, valves, and other steel tubing products.